MONTREAL, June 19, 2013 /CNW Telbec/ - Chairman of the Board Martin
Godbout is pleased to announce the appointment of three new members to
the Génome Québec board of directors, following the organization's
annual general meeting held yesterday in Montréal.
Christiane Ayotte is Professor and Director at the Doping Control Laboratory of the
INRS-Institut Armand Frappier. A chemist by training, she is known for
her breakthrough research on the screening of doping substances. Along
with her team, she has developed screening methods to detect anabolic
steroids and other performance-enhancing drugs. She also serves as a
scientific expert on several committees and forums, such as the World
Anti-Doping Agency and the International Olympic Committee Medical
Egidio Nascimento is Chief Financial Officer at Variation Biotechnologies Inc. During his
career, he has held several high-level finance positions for leading
companies. From 2002 to 2006, he also served as VP of Finance for
Genome Canada, where he gained a wealth of knowledge and expertise in
the fields of biotechnology and genomics.
Jacques Simoneau is President and CEO and a board member at Gestion Univalor. An
engineer by trade, he currently sits on the board of several companies.
He began his career as a professor and scientist and went on to gain
solid expertise in venture capital and investments through management
positions with the Solidarity Fund QLF and the Business Development
Bank of Canada.
In the current global environment marked by rapid change and fierce
competition, Québec must rank among the best and position itself as a
leader in science and innovation, according to Mr. Godbout. He went on
to add: "We are extremely proud and fortunate to welcome new board
members with such impressive track records. Our organization will be
greatly served by the international, scientific, commercial and
financial expertise and counsel of these seasoned advisors."
The Chairman also bid farewell to two outgoing board members, Monique
Letourneau and Raymond Langlois, and thanked them for their outstanding
contribution over the last two years, particularly in support of the
sound management of Génome Québec's finances and investments.
About Génome Québec
Since May 2000, Génome Québec has been the driving force behind the
development of genomics in Québec. By supporting over 80 projects and
800 researchers and managing the operations of the McGill University
and Génome Québec Innovation Centre, Génome Québec is helping to
accelerate the discovery of new applications for genomics in strategic
areas, such as human health, forestry and the environment.
The funds invested by Génome Québec are provided by the Ministry of
Higher Education, Research, Science and Technology, the Government of
Canada, through Genome Canada, and private partners.
For more information, visit www.genomequebec.com.
SOURCE: Génome Québec
For further information:
Public Relations Officer
514 398-0668, ext. 206